Survival Similar for Hemodialysis, Peritoneal Dialysis
WEDNESDAY, Feb. 12, 2020 -- Peritoneal dialysis (PD) and in-center hemodialysis (HD) carry similar survival benefits, according to a review published online Jan. 28 in Nephrology Dialysis Transplantation. Mohamed E. Elsayed, M.B.B.S., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news

Fluid resuscitation in patients with end-stage renal disease on hemodialysis presenting with severe sepsis or septic shock: A case control study
Due to the potential risk of volume overload, physicians are hesitant to aggressively fluid-resuscitate septic patients with end-stage renal disease (ESRD) on hemodialysis (HD). Our study indicates that aggressive fluid resuscitation appears to be safe in ESRD patients. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 23, 2020 Category: Consumer Health News Source Type: news

Online Patient Portal Use May Up Likelihood of Kidney Transplant
TUESDAY, Jan. 14, 2020 -- For hemodialysis patients, use of an online portal is associated with an increased likelihood of receiving a kidney transplant at four or five years, according to a study published online Jan. 8 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2020 Category: Pharmaceuticals Source Type: news

Associations between the measures of physical function, risk of falls and the quality of life in haemodialysis patients: a cross-sectional study - Vanden Wyngaert K, Van Craenenbroeck AH, Eloot S, Calders P, Celie B, Holvoet E, Van Biesen W.
BACKGROUND: Impaired physical function due to muscle weakness and exercise intolerance reduces the ability to perform activities of daily living in patients with end-stage kidney disease, and by consequence, Health-Related Quality of Life (HRQoL). Furtherm... (Source: SafetyLit)
Source: SafetyLit - January 13, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Man dies after stopping hemodialysis to send message to Yukon government
Whitehorse resident Terry Coventry stopped life-saving hemodialysis in Vancouver because he wanted to send a message to the government in Yukon, where the treatment wasn't available for him, said his sister. (Source: CBC | Health)
Source: CBC | Health - January 3, 2020 Category: Consumer Health News Tags: News/Canada/North Source Type: news

Endovascular AVF for Dialysis Access Shows High Patency Rate
THURSDAY, Dec. 12, 2019 -- A proximal radial artery endovascular arteriovenous fistula to allow vascular access in patients who require hemodialysis remains highly functional at two years, according to a study recently published online in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2019 Category: Pharmaceuticals Source Type: news

Percutaneous Device for Dialysis Access'a Significant Advance'Percutaneous Device for Dialysis Access'a Significant Advance '
A novel endovascular device is a new alternative to surgery for the creation of an arteriovenous fistula for hemodialysis access in those with kidney disease, and has a high level of patient satisfaction.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 11, 2019 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Can't get hemodialysis at home, Yukon man opts to forgo treatment to put pressure on health authorities
A 74-year-old man from Whitehorse says he’s going to stay in the city for his final days, forgoing life-saving hemodialysis available to him in Vancouver, to inspire the government to offer the treatment close to home. (Source: CBC | Health)
Source: CBC | Health - December 11, 2019 Category: Consumer Health News Tags: News/Canada/North Source Type: news

Medtronic FDA Approval Marks a Turnaround in the Paclitaxel Story
Paclitaxel-coated balloons and paclitaxel-eluting stents caused quite the stir for manufacturers and physicians this year, but an FDA approval this week marks a major step forward for this category of devices. The agency approved Medtronic's IN.PACT AV drug-coated balloon for the treatment of failing arteriovenous access in patients with end-stage renal disease (ESRD) undergoing dialysis. AV fistulae are created and used to enable hemodialysis for patients with ESRD. Over time, vessel restenosis limits the ability to use AV fistulae effectively. In order to restore function, patients often undergo one to three ...
Source: MDDI - November 22, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news

Ambulatory Hemodialysis Could Improve Prospects of ESRD Patients, but Hurdles Remain Ambulatory Hemodialysis Could Improve Prospects of ESRD Patients, but Hurdles Remain
Ambulatory hemodialysis could give greater freedom to patients with end-stage renal disease (ESRD), but several technical hurdles remain, according to a new review.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 22, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news

Osteoporosis Screening Often Missed in Patients With ESRD Osteoporosis Screening Often Missed in Patients With ESRD
Women with ESRD on hemodialysis are rarely screened for osteoporosis despite the fact they are at high risk for bone diseases compared with the general population.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 15, 2019 Category: Endocrinology Tags: Nephrology News Source Type: news

ASN: Difelikefalin Improves Itch in CKD-Linked Pruritus
TUESDAY, Nov. 12, 2019 -- For patients undergoing hemodialysis who have moderate-to-severe pruritus, difelikefalin is associated with a significant reduction in itch intensity and improvement in itch-related quality of life, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 12, 2019 Category: Pharmaceuticals Source Type: news

Hospitalizations among dialysis patients are higher in areas with more black residents
(American Society of Nephrology) Patients receiving hemodialysis at facilities   located in residential areas with a high percentage of Black residents have a higher rate of hospitalization. Results from the study will be presented at ASN Kidney Week 2019 Nov. 5-10 at the Walter E. Washington Convention Center in Washington, D.C. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2019 Category: International Medicine & Public Health Source Type: news

Diality Secures $10 million in Series A Funding
IRVINE, Calif., Nov. 5, 2019 -- (Healthcare Sales & Marketing Network) -- Diality Inc. (diality.com), a medical device company that is redefining home dialysis by developing a smart, flexible and portable home hemodialysis machine, today announced the clo... Devices, Venture Capital Diality, home hemodialysis, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2019 Category: Pharmaceuticals Source Type: news

Expanding Home Dialysis for Kidney Disease Feasible and Safe Expanding Home Dialysis for Kidney Disease Feasible and Safe
Expanding home dialysis as an initial therapy for end-stage renal disease is feasible and safe, and produces better outcomes among patients than starting them on center-based hemodialysis.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 13, 2019 Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news

A demonstration project on the impact of safety culture on infection control practices in hemodialysis
Infections among hemodialysis patients continues to be major causes of morbidity and mortality despite advances in the science of infection prevention. Many infections are potentially preventable, yet research suggests that evidence-based interventions are not uniformly practiced in dialysis settings. The purpose of the project was to reduce the risk of infection among hemodialysis patients in an outpatient dialysis clinic in upstate New York through the development of an enhanced patient safety culture. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 12, 2019 Category: Consumer Health News Source Type: news

Fatal external bleeding from self-severed arterial dialysis tube: an unusual method of suicide - Srettabunjong S.
A high risk of suicide has been observed in adults with end-stage renal disease who are undergoing haemodialysis. Since suicide is preventable, early screening, a prompt multidisciplinary approach and appropriate treatment of depression are critical and... (Source: SafetyLit)
Source: SafetyLit - September 7, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Exsanguination from a puncture wound to arteriovenous fistula as the method of suicide in a chronic kidney disease patient - Zivkovi ć V, Cvetković D, Nikolic S.
In this paper we present a case of a 65-year-old man, with chronic kidney insufficiency treated with hemodialysis, found dead by his wife, lying in his bed. Based on autopsy findings, toxicological analysis, the police report and circumstances of death, it... (Source: SafetyLit)
Source: SafetyLit - September 7, 2019 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Shockwave Gets a Little Pep in Its Step with Breakthrough Device Designation
The regulatory pathway for Shockwave Medical’s Intravascular Lithotripsy (IVL) technology just received a huge jolt from FDA. The agency granted the Santa Clara, CA-based company breakthrough device designation for the Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter. The firm’s device is designed to fracture problematic calcium using sonic pressure to facilitate stent delivery, deployment, and optimal expansion, thereby improving blood flow to the heart muscle. Shockwave’s technology is being evaluated in the DISRUPT CAD III, a prospective, non-randomiz...
Source: MDDI - September 4, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Cardiovascular Source Type: news

Another Breakthrough Designation for Concept Medical
Concept Medical’s MagicTouch AVF might have the “magic touch” when it comes down to nabbing breakthrough device designations. The proposed indication for the latest breakthrough device designation is for the treatment of stenotic lesions of Arteriovenous Fistulae or Arteriovenous graft in the hemodialysis treatment of renal failure. Concept Medical said its first pilot study to investigate the safety and efficacy of Magic Touch PTA Sirolimus balloon was started in Singapore in 2018. Led by Principal Investigator, Dr. Tan Chieh Suai, a multi-disciplinary team of doctors ...
Source: MDDI - September 3, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Brooklyn firm brings dialysis to 5 WNY nursing homes
A Brooklyn-based healthcare provider is expanding into Western New York with dialysis services for nursing homes. DialyzeDirect provides home hemodialysis services to older adult patients living in skilled nursing facilities with end stage renal disease. Joshua Rothenberg, chief operating officer and co-founder of Dialyze Direct, said Western New York was an attractive market for expansion because of its la rge dialysis patient population, and the challenges posed by harsh weather in getting to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2019 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Brooklyn firm brings dialysis to 5 WNY nursing homes
A Brooklyn-based healthcare provider is expanding into Western New York with dialysis services for nursing homes. DialyzeDirect provides home hemodialysis services to older adult patients living in skilled nursing facilities with end stage renal disease. Joshua Rothenberg, chief operating officer and co-founder of Dialyze Direct, said Western New York was an attractive market for expansion because of its la rge dialysis patient population, and the challenges posed by harsh weather in getting to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 8, 2019 Category: Biotechnology Authors: Tracey Drury Source Type: news

Vascular Graft Solutions Announces CE Mark Approval for FRAME FR External Support for AV Fistula Repair
TEL AVIV, Israel, Aug. 5, 2019 -- (Healthcare Sales & Marketing Network) -- VGS - Vascular Graft Solutions Ltd. announced today it has received CE Mark Approval for the FRAME FR, a novel solution for repair and stabilization of high flow and aneurysmal ar... Devices, Regulatory Vascular Graft Solutions, FRAME FR, arteriovenous fistula, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 5, 2019 Category: Pharmaceuticals Source Type: news

Discovery that patients with end-stage kidney disease on hemodialysis are at high risk for allergic reaction to a common antiseptic leads to change in hospital policy at St. Michael’s, UHN
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - July 18, 2019 Category: Hospital Management Tags: Hospital News Source Type: news

Trump signs executive order revamping kidney care, organ transplantation
A package of initiatives aims to prolong lives, offer alternatives to center-based hemodialysis and save money. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 10, 2019 Category: Consumer Health News Authors: Lenny Bernstein Source Type: news

DaVita, Fresenius slide on Trump threat to overhaul dialysis market
Shares of dialysis providers DaVita Healthcare (NYSE:DVA) and Fresenius (NYSE:FMS) took a hit today after a report surfaced that the Trump administration is readying an overhaul of the kidney treatment market. The president plans to issue an executive order tomorrow that would seek to incentivize kidney transplants and home hemodialysis in a bid to lower the federal government’s annual $100 billion kidney care tab, Politico reported, citing “two individuals with knowledge of the announcement.” The strategy involves new payment models from the U.S. Health & Human Services Dept. designed to move pa...
Source: Mass Device - July 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Dialysis Featured Wall Street Beat DaVita Inc. Dept. of Health & Human Services (HHS) Fresenius Source Type: news

Advent Access wins CE Mark for dialysis device
The av-Guardian vascular access system designed for hemodialysis patients. (Image from Advent Access) Singapore-based vascular access device company Advent Access said it has received the CE Mark for its av-Guardian technology designed to create vascular access for dialysis patients. The device-guided needling platform features the company’s “guardian guide-door” technology for accessing arteriovenous fistulas, which it claims can reduce wear and tear on the dialysis patient’s veins. The technology may be used in a dialysis center or at home, regardless of the types of dialysis machine being used, a...
Source: Mass Device - July 5, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Dialysis Featured News Well Regulatory/Compliance Advent Access CE Mark Source Type: news

Second-chance placement of hemodialysis patients after involuntary discharge for disruptive behavior - Allon M, Thornley-Brown D, Rizk DV, Carrasquillo AJ.
A small subset of hemodialysis patients exhibits persistently disruptive behavior. When all reasonable attempts to stop such behavior have been exhausted, they may undergo involuntary discharge from their dialysis unit. Such patients typically present repe... (Source: SafetyLit)
Source: SafetyLit - July 2, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Potassium-Removing Drug Effective in Dialysis Patients Potassium-Removing Drug Effective in Dialysis Patients
Sodium zirconium cyclosilicate effectively treats hyperkalemia in patients receiving hemodialysis for end-stage kidney disease, and no new safety concerns were observed in the phase 3 DIALIZE study.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 21, 2019 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Maintaining Work During Dialysis Tied to Higher Survival
FRIDAY, June 21, 2019 -- Working in the six months before initiating hemodialysis (HD) is associated with better survival, according to a large study published online June 14 in the Clinical Kidney Journal. Yuxin Nie, from Fudan University in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2019 Category: Pharmaceuticals Source Type: news

One in Five Surgeons Still Using Low-Value Arteriovenous Graft for Dialysis Access One in Five Surgeons Still Using Low-Value Arteriovenous Graft for Dialysis Access
One in five surgeons who do hemodialysis access procedures continue to use arteriovenous grafts (AVG) instead of the recommended best practice of arteriovenous fistula (AVF), researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2019 Category: Consumer Health News Tags: General Surgery News Source Type: news

Many Surgeons Still Performing Inappropriate Vascular Access Sx
WEDNESDAY, June 19, 2019 -- For patients with first-time permanent hemodialysis access placement, more than one-fifth of surgeons have arteriovenous graft (AVG) use rates exceeding the recommended best practice guideline of 34 percent, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2019 Category: Pharmaceuticals Source Type: news

Working in the last 6 months before haemodialysis is associated with a better survival
(ERA-EDTA) In a study published in CKJ, 26% of patients were employed 6 months prior to dialysis start -- but this fell to 15% when dialysis began. The study also showed that being made redundant increased mortality. Although no causal relationship can be inferred, Professor Alberto Ortiz, CKJ ´ s editor-in-chief concludes, 'We should encourage our CKD patients to stay employed while on dialysis and support them to balance work and treatment.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2019 Category: International Medicine & Public Health Source Type: news

One-fifth of US surgeons still overusing riskier procedure to create kidney dialysis access
(Johns Hopkins Medicine) Long-term hemodialysis is a lifesaver for approximately half a million patients in the United States with kidney failure (also known as end-stage renal disease, or ESRD) who are either waiting on or unsuitable for a kidney transplant. But before the external machinery can take over the function of the kidneys -- filtering and cleansing wastes from the blood -- a minor surgical procedure is needed to create a stable, functional and reusable access to the circulatory system, usually through blood vessels in the arm. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2019 Category: International Medicine & Public Health Source Type: news

New study evaluates transcatheter dialysis conduit procedures over 15 years
(Harvey L. Neiman Health Policy Institute) A new research study by Harvey L. Neiman Health Policy Institute found that utilization of invasive procedures on hemodialysis conduits -- artificially constructed shuts used by many individuals who require dialysis -- increased markedly from 2001 through 2015 for nephrologists and declined for radiologists. The study is published online in the Journal of Vascular and Interventional Radiology (JVIR). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 29, 2019 Category: International Medicine & Public Health Source Type: news

Cameroon: Buea Regional Hospital - Haemodialysis Centre Receives Four New Machines
[Cameroon Tribune] The Elone Foundation and Cameroon People's Democratic Movement (CPDM) Section UK and Northern Ireland decided to ameliorate the condition of haemodialysis patients of Buea Hospital Region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 16, 2019 Category: African Health Source Type: news

Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study - Khan A, Khan AH, Adnan AS, Sulaiman SAS, Mushtaq S.
BACKGROUND: Even though depression is one of the most common psychiatric disorders, it is under-recognized in hemodialysis (HD) patients. Existing literature does not provide enough information on evaluation of predictors of depression among HD patients. T... (Source: SafetyLit)
Source: SafetyLit - May 14, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

For-profit dialysis provider charges private insurers four times more than government payers
This study corroborates these findings in the dialysis market and could lead to policies that reduce the prices paid, in particular by private insurers.AUTHORSThe authors are Dr. Christopher Childers, Dr. Jill Dworsky and Dr. Melinda Maggard-Gibbons of the department of surgery, David Geffen School of Medicine at UCLA; and Gerald Kominski of the UCLA Center for Health Policy Research in the UCLA Fielding School of Public Health.JOURNALThestudy is published in JAMA Internal Medicine.FUNDINGThe Agency for Healthcare Research and Quality in the Department of Health and Human Services funded this study. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - May 14, 2019 Category: Universities & Medical Training Source Type: news

Global Burden of Kidney Disease High, Inequities in Care Common Global Burden of Kidney Disease High, Inequities in Care Common
By 2030, 14.5 million people around the world will have end-stage kidney disease (ESKD), yet only 5.4 million will be treated due to economic, social and political factors. And more than 2 million people will die each year due to little or no access to hemodialysis or kidney transplantation.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 20, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news

Trial Results Unclear for Benefit of Longer Hemodialysis Sessions
THURSDAY, April 18, 2019 -- Intervention uptake was insufficient to allow evaluation of its impact in a pragmatic trial designed to assess the effect of longer hemodialysis duration on death and other outcomes; the findings from the Time to Reduce... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2019 Category: Pharmaceuticals Source Type: news

A case report of massive acetaminophen poisoning treated with a novel "triple therapy": N-acetylcysteine, 4-methylpyrazole, and hemodialysis - Kiernan EA, Fritzges JA, Henry KA, Katz KD.
Massive acetaminophen (N-acetyl-p-aminophenol; APAP) ingestion is characterized by a rapid onset of mitochondrial dysfunction, including metabolic acidosis, lactemia, and altered mental status without hepatotoxicity which may not respond to the standard do... (Source: SafetyLit)
Source: SafetyLit - April 11, 2019 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Psychoactive Medications in Older Adults on Hemodialysis Psychoactive Medications in Older Adults on Hemodialysis
Are psychoactive medications, such as sedative-hypnotics, and antidepressants with anticholinergic properties, associated with major adverse outcomes among older hemodialysis patients?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2019 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

FTC grants final approval for Fresenius ’ s $2B buyout of NxStage
The U.S. Federal Trade Commission said yesterday that it granted a final order of approval to Fresenius Medical Care (NYSE:FMS; ETR:FRE) for its $2 billion acquisition of NxStage Medical. The approval came with a caveat that the companies divest their assets and rights to research, develop, manufacture, market and sell NxStage’s bloodline tubing sets intended for use during hemodialysis treatment. To mollify the anti-trust regulators, NxStage last July agreed to deal its Medisystems bloodlines business to B. Braun. The final order was approved in a three-to-two vote, according to an FTC posti...
Source: Mass Device - April 10, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dialysis Featured Mergers & Acquisitions Wall Street Beat Fresenius NxStage Medical Inc. Source Type: news

Pursuit Vascular Announces CE Mark Approval for ClearGuard HD Caps
Milestone opens international markets for the company MAPLE GROVE, Minn., April 3, 2019 -- (Healthcare Sales & Marketing Network) -- Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, today announced that the company... Devices, Regulatory, Product Launch Pursuit Vascular, ClearGuard, Antimicrobial Barrier, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2019 Category: Pharmaceuticals Source Type: news

Two Therapies for Treating Depression in Dialysis Patients Two Therapies for Treating Depression in Dialysis Patients
Dr Bansal describes a new study that compares CBT and sertraline for depressed patients on hemodialysis for end- stage renal disease.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 1, 2019 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Hemodialysis device maker Phraxis raises $6m
Early stage medical device company Phraxis has raised approximately $5.6 million in a new round of equity and options financing, according to a recently posted SEC filing. Phraxis is developing a novel treatment for patients who need vascular access for hemodialysis, according to the company’s website. The St. Paul, Minn.-based company’s first product for commercialization is the InterGraft, a percutaneously delivered arteriovenous shunt intended to provide a unique, non-surgical approach for patients who need vascular access, according to the site. Money in the round came from seven unnamed investors, with the...
Source: Mass Device - March 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Phraxis Inc. Source Type: news

Fresenius Awarded Breakthrough Device Designation for Software
Fresenius Medical Care hit a significant milestone last week with its software to enhance its line of hemodialysis machines. FDA granted breakthrough device designation to the  company’s computer-assisted ultrafiltration control software. The software is in development to improve fluid management during hemodialysis and personalize treatments. Fluid management is a critical concern for dialysis patients, as both fluid overload and fluid depletion are associated with adverse cardiovascular events, morbidity and mortality. Working with the CLiC device which enables relative blood volume monitori...
Source: MDDI - March 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Fresenius wins FDA breakthrough device nod for fluid management software
Fresenius (NYSE:FMS) said yesterday that it won FDA breakthrough device designation for its computer-assisted ultrafiltration control software intended to improve fluid management during hemodialysis. The Waltham, Mass.-based company said that the software is designed to work with its newer hemodialysis machines using its CLiC device. Fresenius said that with the software, it hopes to create a dialysis machine with embedded intelligent diagnostics to provide computer-assisted recommendations for achieving target levels of relative blood volume. “This new software represents our commitment to driving innovation a...
Source: Mass Device - March 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Dialysis Featured Food & Drug Administration (FDA) Software / IT Fresenius Source Type: news

St. Paul firm pursuing easier hemodialysis treatments closes on nearly $6 million round
St. Paul-based Phraxis Inc.'s device offers an alternative to a central venous catheter. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 13, 2019 Category: American Health Authors: Alex Wittenberg Source Type: news

St. Paul firm pursuing easier hemodialysis treatments closes on nearly $6 million round
St. Paul-based Phraxis Inc.'s device offers an alternative to a central venous catheter. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 13, 2019 Category: Biotechnology Authors: Alex Wittenberg Source Type: news